PEPFAR, the acclaimed anti-HIV program, faces loss of funds as part of U.S. aid pause
Briefly

The Trump administration has immediately halted nearly all U.S. global health funding, including for PEPFAR, a vital HIV/AIDS program launched in 2003. With a $6.5 billion annual budget, PEPFAR supports over 20.6 million individuals by providing medications, testing, and education aimed at preventing the spread of HIV/AIDS. The decision came via a State Department cable following a January executive order and may impact operations for at least three months. The move has alarmed many in the global health community, as PEPFAR has historically enjoyed bipartisan support and has saved millions of lives since its inception.
With its $6.5 billion annual budget, PEPFAR provides HIV/AIDS medications for over 20.6 million people, preventing transmission and saving lives through testing and education.
The halt on funding means PEPFAR faces a pause in operations for at least three months, sending shock waves through the global health community.
Read at www.npr.org
[
|
]